Immediate Impact
54 standout
Citing Papers
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2025 Standout
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
2025 Standout
Works of Dei‐In Tang being referenced
Closed Testing Procedures for Group Sequential Clinical Trials with Multiple Endpoints
1999
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Dei‐In Tang | 295 | 169 | 119 | 19 | 523 | |
| Gavin G. Gregory | 117 | 40 | 20 | 18 | 525 | |
| John Crosbie | 61 | 37 | 37 | 26 | 613 | |
| Terence Reilly | 71 | 104 | 14 | 13 | 612 | |
| William P. Cleveland | 22 | 88 | 45 | 19 | 566 | |
| Robert Bohrer | 230 | 104 | 7 | 45 | 633 | |
| Richard Brook | 79 | 18 | 79 | 25 | 488 | |
| Alessandro Baldi Antognini | 178 | 143 | 12 | 31 | 487 | |
| Nils Blomqvist | 98 | 38 | 29 | 20 | 533 | |
| Tuhao Chen | 77 | 40 | 34 | 13 | 647 | |
| Josep Fortiana | 232 | 55 | 28 | 23 | 467 |
All Works
Loading papers...